Reported Oct 25, 2023 · Terminated
Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 600 mcg/0.4mL (150 mcg/0.1mL) Syringe, Rx…
Pine Pharmaceuticals, LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Pine Pharmaceuticals, LLC · 355 Riverwalk Pkwy · Tonawanda, NY · 14150-5837
Is this the product you have?
- Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 600 mcg/0.4mL (150 mcg/0.1mL) Syringe, Rx only
- Compounded by
Pine Pharmaceuticals 355 Riverwalk ParkwayTonawandaNY 14150
- Lot codes and dates
Lot #: 67480Exp. Date 10/9/202368640Exp. Date 12/3/202368769Exp. Date 12/9/202368760Exp. Date 12/10/202368925Exp. Date 12/16/202370119Exp. Date 1/20/2024
- Amount recalled
- 2484 syringes
This recall covers 16 products
The agency filed one notice per product. You are reading one of them; the other 15 are below.
3 more are in the archive.
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Pine Pharmaceuticals, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.